• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN SPIDER FX; CATHETER, CAROTID, TEMPORARY, FOR EMBOLIZATION CAPTURE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN SPIDER FX; CATHETER, CAROTID, TEMPORARY, FOR EMBOLIZATION CAPTURE Back to Search Results
Device Problems Patient-Device Incompatibility (2682); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intimal Dissection (1333); Pulmonary Embolism (1498); Bradycardia (1751); Stroke/CVA (1770); Low Blood Pressure/ Hypotension (1914); Myocardial Infarction (1969); Stenosis (2263)
Event Date 10/25/2016
Event Type  Injury  
Manufacturer Narrative
Title: endovascular treatment for near occlusion of the internal carotid artery: 30-day outcome and long-term follow-up journal: clinical neuroradiology doi 10.1007/s00062-016-0546-8 clin neuroradiol (2018) 28:245¿252 age/date of birth: mean age.Sex: majority gender.Event date=date of literature article publication.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Journal: clinical neuroradiology title: endovascular treatment for near occlusion of the internal carotid artery: 30-day outcome and long-term follow-up background: the treatment strategy and the correct incidence of near occlusion (no) of the internal carotid artery (ica) is still controversial.In routine radiological imaging no can easily be misdiagnosed as complete occlusion and there is no consensus on the standard treatment strategy.Purpose: to present our perioperative and long-term followup results of ica no patients treated with carotid artery stenting (cas).Material and methods: between 2004¿2014 a total of 182 patients with ica no were evaluated for cas.The study included 132 male (72.5 %) and 50 female (27.5 %) patients with a mean age of 70.2 years.Patients underwent a clinical neurological evaluation and radiological imaging of the carotid arteries before the cas procedure.Of the patients 80 (44 %) were asymptomatic.The median clinical and carotid doppler ultrasound (dus) follow-up period was 64 months (range 18¿124 months).A percutaneous transfemoral approach was used for cas in all cases.All lesions were pre-dilated and embolic protection was used.After pre-dilatation, intimal dissection was seen in 29 patients which was treated with stenting.Results: in 182 patients cas were performed, 4 patients (2.2 %) developed minor stroke, 2 patients (1.1 %) developed myocardial infarction but no major stroke or death occurred in the following 30-day period.One patient stopped taking dual antiplatelet medication after discharge from hospital and developed and ipsilateral major stroke 45 days after the procedure.Asymptomatic restenosis was detected in seven patients (3.8 %) in the follow-up period.These patients were treated with stents and post dilation.During the subsequent follow-up period 21 patients died ¿ 12 from vascular causes and 9 from nonvascular causes.Conclusion: with sufficient neurological evaluation during pretreatment and posttreatment periods and when the procedure is performed with technologically developed products by an experienced interventional team, cas is beneficial in patients with ica no.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPIDER FX
Type of Device
CATHETER, CAROTID, TEMPORARY, FOR EMBOLIZATION CAPTURE
Manufacturer (Section D)
COVIDIEN
4600n nathan lane
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600n nathan lane
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key7674098
MDR Text Key113565499
Report Number2183870-2018-00372
Device Sequence Number1
Product Code NTE
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
K111010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/10/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/08/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
-
-